# C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer

> **NCT00804245** · PHASE1 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 18 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** needle biopsy
- **DRUG:** PET-CT scans supplemented with 11C-Choline tracer

## Key facts

- **NCT ID:** NCT00804245
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2012-06
- **Final completion:** 2013-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00804245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00804245, "C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00804245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*